BIOCOMMUNIQUE: December 17, 2009
- Cover Story
- BIOCOM News
- Public Policy News
- BIOCOM Events
- Workforce Development
- Purchasing Group
- Deals and Data
- Member News
- Santaris Pharma Proprietary LNA Technology Holds Promise for Hep C
- Scripps Study Describes Powerful New Tool in Fighting Autoimmune Diseases, Blood Cancers
- New UCSD Med Center CEO to Lead Ambitious Agenda
- Scripps’ Young Tech Transfer Boss Seeks to Cut Deals With Industry, Not Just Push Paper
- UC San Diego Researchers Study Adolescent Obesity and Weight Loss
- Biogen Idec’s Dream: Antibodies That Kill Two Birds With One Stone
- $17 Million to UC San Diego for Methamphetamine/AIDS Research
- John Crawford Joins Clearity Board
- La Jolla Institute Enhances Disease Focus with Five New Faculty
- Member Events
- Member List
- About BIOCOM